Weekend Health

What Weekend Health does

Weekend Health, Inc. is a US-based telehealth company founded in 2021 that operates a digital health platform connecting patients with board-certified obesity specialists for personalized weight management care. Its core product, Sequence, is a subscription-based program offering access to clinical consultations, weight management medications, and ongoing health coaching through a proprietary website and mobile application, with availability extended to evenings and weekends to bypass the constraints of traditional clinic hours. The company generates revenue through recurring monthly subscriptions automatically billed via Stripe and Square, targeting US adults seeking accessible, transparent, and personal care for obesity and related chronic conditions.

Underlying the offering is a remote-first clinical delivery model supported by a wholly-owned clinical subsidiary, Weekend Health of Texas, P.A., enabling provider-based service delivery across multiple US states. The technology stack is primarily a standard digital health platform with integrated payment processing, web analytics, and social media connectivity; no proprietary AI/ML components are evidenced. The company raised approximately $25.95 million in venture funding across two rounds led or participated in by DCM Ventures before being acquired by WeightWatchers for $132 million in 2023, at which point it became a wholly-owned subsidiary within WW's structure while maintaining independent operations and serving as the foundation of WeightWatchers' technology-driven healthcare strategy.

Name

Weekend Health

Legal name

Weekend Health, Inc.

Website

https://weekendhealth.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

251–500 employees

Short description

Weekend Health is a US telehealth platform founded in 2021 that connects patients with board-certified obesity specialists through a subscription-based digital program called Sequence, offering weight management medications and coaching. Acquired by WeightWatchers for $132M in 2023, it operates as WW's tech-driven healthcare foundation.

Ownership category

akta.pro rank

Product category

Telehealth Weight Management

NAICS

Offices of Physicians (6211)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)

Keywords

• Telehealth weight management
• Obesity care platform
• Medical weight loss
• Digital health subscription
• Remote specialist consultations

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Subscription-Based Healthcare Services: Products available for purchase through the Services require subscription-based purchase. Payment is automatically charged at regular intervals. The company may modify subscription fees upon 30 days prior written notice.
2. Healthcare Product Subscriptions: All products require subscription purchase with automatic recurring billing at the beginning of each subscription period. Promotional rates may be offered for new subscribers.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

Weekend Health operates a digital health platform that delivers science-based weight management care directly to consumers via telehealth. Its flagship offering, Sequence, is a subscription program connecting members with board-certified obesity specialists and health coaches, and providing access to weight management medications, all delivered remotely on evenings and weekends through a website and mobile app.

Product overview

Weekend Health operates as a digital health platform focused on making healthcare more accessible, transparent, and personal. The company offers a single core product called Sequence (joinsequence.com), a scientific weight loss program. Sequence connects members with board-certified obesity specialists and health coaches to provide comprehensive weight management care, including access to weight management medications. The platform was acquired by WeightWatchers for $132 million and operates as part of the WW Clinic division while maintaining independent operations.

Differentiator

Problem solved

Functional benefit

Brands

• Sequence: Scientific weight loss program offering access to board-certified obesity specialists and weight management medications

Products and services

• Sequence Sequence is a scientifically-backed weight loss subscription program delivered through Weekend Health's telehealth platform. It connects members with board-certified obesity specialists for personalized weight management care, provides access to weight management medications, and pairs members with health coaches for ongoing support. It is targeted at US adults seeking accessible, medically-supervised obesity care and is sold via a recurring monthly subscription on joinsequence.com.

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature2 records

Partnerships

One partnership is on record.

• WeightWatcherscoreStrategic or Co-development PartnerWeekend Health was acquired by WeightWatchers for $132 million in 2023 to expand their mission to millions more members. The team remains the same and continues to operate independently as the foundation of WeightWatchers' future growth as a tech company. The acquisition provides expanded reach and brand backing while maintaining operational independence.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Form Health: Form Health provides obesity medicine via board-certified physicians through a telehealth platform, overlapping directly with Weekend Health's board-certified specialist model and weight-loss medication focus.
• Noom: Noom is a subscription-based digital weight-loss program combining behavior change with optional clinician and medication access (Noom Med). Directly competes for the same DTC weight-loss subscriber and increasingly in the medication-assisted tier.
• Found: Found is a direct competitor offering telehealth-based weight management combining clinician care with medication access on a subscription basis, closely mirroring Weekend Health's Sequence offering.
• Calibrate: Calibrate is a direct competitor in clinician-supervised, medication-assisted weight loss delivered via telehealth with a subscription model. Operates in the same Sequence category targeting the same GLP-1-enabled obesity care market.

Emerging players

• Virta Health: Virta Health is a telehealth platform for chronic metabolic disease (type 2 diabetes, prediabetes, obesity) with clinician-led care and subscription/payer contracting models. Adjacent in chronic-disease telehealth and chronic-condition remote care orchestration.
• Omada Health: Omada Health is a digital chronic-disease prevention and management platform (diabetes, hypertension, obesity) combining coaching and connected devices via employer/payer contracts. Comparable on chronic-condition telehealth platform infrastructure, though primarily B2B.

Broad incumbents

• Teladoc Health: Teladoc is a large incumbent telehealth platform with chronic-condition management (including diabetes and hypertension via its Livongo acquisition). Comparable as a chronic-care telehealth infrastructure provider, though broader and B2B-leaning.
• Ro: Ro is a multi-condition DTC telehealth platform (Roman, Rory, Ro Body) that has expanded into weight management. Comparable on telehealth infrastructure, subscription model, and clinician-supervised prescribing, though it spans more therapeutic areas.
• Weight Watchers (WW International): WW is Weekend Health's parent company and the legacy behavioral weight-loss brand. Comparable as the consumer-facing weight-loss subscription category leader and the platform through which Sequence distributes.
• Hims & Hers Health: Hims & Hers is a scaled DTC telehealth platform that has expanded into weight-loss treatment (including GLP-1 access). While broader in scope, it now competes head-on with Sequence in the consumer weight-loss category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Weekend Health